Their new vaccine helps smokers quit

Have a question for the tobacco researchers?

post your questionread the answers

Post your questions here for Paul Pentel and Dorothy Hatsukami. We'll pick the best ones and post his answers.

Doctors Paul Pentel and Dorothy Hatsukami, of the Transdisciplinary Tobacco Use Research Center (TTURC) at the University of Minnesota, are studying a vaccine that could help smokers kick the habit.

“The vaccine reduces the pleasurable effects from smoking and reduces the addiction to nicotine.”

The nicotine vaccine, called NicVax, causes the body to produce antibodies that bind to nicotine and prevent it from reaching the brain. Early clinical trials in humans show that it’s safe, has few side effects, and may reduce smoking and improve quitting rates.